IP Library Granted Patent US 7,998,702
Granted Patent B2
US 7,998,702 · App. 12/212,271 · Granted Aug 16, 2011

Mutant arabinose promoter for inducible gene expression

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,998,702
App. No.
12/212,271
Granted
Aug 16, 2011
Kind
B2
Abstract

An L-arabinose inducible expression system comprising a mutant arabinose promoter. This system exhibits an increase in heterologous protein production upon induction with L-arabinose and comprises a mutant araB promoter and an AraC transcription binding region. This system retains the tight regulatory control characteristic of the wild type arabinose operon.

Claims (36)

1. An isolated nucleic acid molecule encoding an araB promoter comprising a nucleic acid sequence SEQ ID NO: 2.

2. The isolated nucleic acid molecule of claim 1 , further comprising an AraC transcription factor binding region operably linked to SEQ ID NO: 2.

3. The isolated nucleic acid molecule of claim 2 , wherein the AraC transcription factor binding region comprises SEQ ID NO: 33.

4. An expression cassette comprising the isolated nucleic acid molecule of claim 2 operably linked to a coding region of interest.

5. An arabinose-inducible expression cassette comprising:

a) an AraC transcription factor binding region;

b) an araB promoter of SEQ ID NO: 2; and

c) a coding region of interest;

wherein the AraC transcription factor binding region, the araB promoter, and the coding region of interest are in operable linkage.

6. The expression cassette of any one of claim 4 or 5 , wherein the coding region of interest encodes for a peptide comprising at least one body surface-binding peptide selected from the group consisting of hair-binding peptides, skin-binding peptides, nail-binding peptides, and teeth-binding peptides.

7. A vector comprising in operable linkage:

a) an AraC transcription factor binding region;

b) an araB promoter comprising a nucleic acid sequence SEQ ID NO: 2;

b) a coding region of interest encoding a polypeptide of interest;

wherein expression of the araB promoter is repressed in the absence of L-arabinose and induced in the presence of an effective amount of L-arabinose.

8. The vector of claim 7 , further comprising at least one transcription terminator operably linked downstream to the coding region of interest.

9. The vector of claim 7 , wherein the AraC transcription factor binding region comprises SEQ ID NO: 33.

10. The vector of claim 7 , wherein the vector further comprises at least one expressible copy of an araC gene.

11. The vector of claim 7 , wherein the coding region of interest encodes from a peptide comprising at least one body surface-binding peptide selected from the group consisting of hair-binding peptides, skin-binding peptides, nail-binding peptides, and teeth-binding peptides.

12. A microbial host cell comprising the vector of any one of claims 7 to 11 .

13. The microbial host cell of claim 12 , wherein the microbial host cell is AraC+.

14. The microbial host cell of claim 13 , wherein the recombinant microbial host cell is a member of the genus Escherichia.

15. The microbial host cell of claim 14 , wherein the recombinant microbial host cell is Escherichia coli.

16. A method of expressing a coding region of interest in a microbial host cell comprising;

a) providing an AraC+ microbial host cell comprising a chimeric gene, said chimeric gene comprising the following nucleic acid molecules in operable linkage:

i) an AraC transcription factor binding region;

ii) an araB promoter of SEQ ID NO: 2; and

iii) a coding region of interest encoding a desired gene product; and

b) contact the microbial host cell of (a) with an effective amount of L-arabinose whereby the coding sequence of interest is expressed and the desired gene product is produced.

17. The method of claim 16 , further comprising:

c) isolating the desired gene product produced in step (b).

18. The method of claim 17 , wherein the chimeric gene is expressed from an expression vector.

19. The method of claim 18 , wherein the expression vector further comprises a transcription terminator operably linked to the coding region of interest.

20. The method of claim 19 , wherein the transcription terminator comprises SEQ ID NO: 28.

21. The method of claim 16 , wherein the coding region of interest encodes for a peptide comprising at least one body surface-binding peptide selected from the group consisting of hair-binding peptides, skin-binding peptides, nail-binding peptides, and teeth-binding peptides.

22. The method of claim 16 , wherein the microbial host cell comprises an arabinose inducible operon comprising SEQ ID NO: 34.

Assignments (3)
CORRECTIVE ASSIGNMENT TO CORRECT THE DESIGNATION OF ASSIGNEE AS A DELAWARE CORPORATION TO A DELAWARE LIMITED LIABILITY COMPANY PREVIOUSLY RECORDED ON REEL 049880 FRAME 0001. ASSIGNOR(S) HEREBY CONFIRMS THE ASSIGNMENT. Recorded Aug 28, 2019
From: E. I. DU PONT DE NEMOURS AND COMPANY
To: DUPONT US HOLDING, LLC
Reel/Frame 051502/0610 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 26, 2019
From: E. I. DU PONT DE NEMOURS AND COMPANY
To: DUPONT US HOLDING, LLC
Reel/Frame 049880/0001 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 3, 2008
From: GRUBER, TANJA MARIA; HUANG, LISA LIXUAN
To: E. I. DU PONT DE NEMOURS AND COMPANY
Reel/Frame 021626/0579 →